Journal Article Characterization of a case of virological failure after switch to long-acting cabotegravir and rilpivirine Get access Maria Mazzitelli, Maria Mazzitelli Infectious and Tropical Diseases Unit, Padua University Hospital, Padua, Italy Corresponding author. E-mail: m.mazzitelli88@gmail.com https://orcid.org/0000-0003-0263-0703 Search for other works by this author on: Oxford Academic PubMed Google Scholar Antonio Avolio, Antonio Avolio Laboratory and Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar Riccardo Carandina, Riccardo Carandina Radiodiagnostic Unit, University Hospital of Padua, Padua, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar Saverio Parisi, Saverio Parisi Department of Molecular Medicine, Padua University Hospital, 35128 Padua, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar Annemarie Wensing, Annemarie Wensing Translational Virology, Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands Search for other works by this author on: Oxford Academic PubMed Google Scholar Annamaria Cattelan Annamaria Cattelan Infectious and Tropical Diseases Unit, Padua University Hospital, Padua, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar Journal of Antimicrobial Chemotherapy, dkae187, https://doi.org/10.1093/jac/dkae187 Published: 21 June 2024
No takes yet. Share an insight, caveat, or question.
Mazzitelli et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: